AMBIQ — Stock Film
STOCK FILMSCENE 1/11AMBIQ · $0.0001
Stock Expert AI presents
AMBIQ
Ambipar Emergency Response
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Ambipar Emergency Response. A quick introduction.

On the stock market since 2020, it operates in the world of heavy industry. It has 7,500 employees. Now — the numbers.

on the stock market since 2020
7,500 employees
$7.2M market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales are growing, year after year.

Average growth of 73% a year over the last 4 years. Red columns mark years that ended in a loss.

$364.3M
2020
$822.2M
2021
$1.7B
2022
$2.6B
2023
$3.2B
2024
In the vault right now:
$0
DEBT: $3.4B
At this pace, that money lasts about 17.5 years.

Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.

What executives did with their own stock over the last 12 months:
2 buy23 sell

Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Thin profit on each sale3/10
WORTH WATCHING

Profit per Sale: The profit kept from each sale is thin.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Sales keep climbing

Over the last 3 years, sales grew about 58% a year on average.

2
THE BRIGHT SIDE · 2/2
Sales are holding up

The company sells $3.2B a year; the problem isn’t sales — it’s costs running above that number.

1
THE RISKS · 1/3
The losses continue

A loss of $20.6M against $3.2B in annual sales.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
Executives lean toward selling

Over the last 12 months, executives reported 23 sells against just 2 buys. Not an alarm bell by itself, but a number worth watching.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, AMBIQ sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: AMBIQ has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film